Współczesna Onkologia

Anticancer effects of fangchinoline in 4T1 breast cancer cells: in vitro and in silico analysis of TGF-β1 and mTOR pathways

Nicolas Kusady 1
,
Denny Satria 1
,
Poppy Anjelisa Zaitun Hasibuan 2
,
Dewi Pertiwi 1
,
Syukur Berkat Waruwu 3
,
Choo Yeun-Mun 4

  1. Department of Pharmaceutical Biology, Faculty of Pharmacy, Universitas Sumatera Utara, Medan, Indonesia

  2. Department of Pharmacology, Faculty of Pharmacy, Universitas Sumatera Utara, Medan, Indonesia

  3. Pharmacist Professional Education, Faculty of Pharmacy and Health Sciences, Universitas Sari Mutiara Indonesia, Medan, Indonesia

  4. Department of Chemistry, Faculty of Science, Universiti Malaya, Kuala Lumpur, Malaysia

Contemp Oncol (Pozn) 2026; 30 (2)

DOI: https://doi.org/10.5114/wo.2026.163119
Data publikacji online: 2026/07/06
Article file
Anticancer effects.pdf
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
  1. Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, et al. Current and future burden of breast cancer: Global statistics for 2020 and 2040. Breast 2022; 66: 15-23.
  2. Gupta K, Walton R, Kataria SP. Chemotherapy-induced nausea and vomiting: pathogenesis, recommendations, and new trends. Cancer Treat Res Commun 2021; 26: 100278.
  3. Yildirim BA, Turker UA. Evaluation of pharmaceutical potentials of naturally and in vitro-grown wild strawberry (Fragaria vesca L.). Prospect Pharm Sci 2025; 23: 56-57.
  4. Chen Z, He T, Zhao K, Xing C. Anti-metastatic activity of fangchinoline in human gastric cancer AGS cells. Oncol Lett 2017; 13: 655-660.
  5. Edosuyi O, Osagiede EB, Eguasa N, Ayodele SO, Eunice EA, Ojonugba ER, et al. Fumarate attenuated doxorubicin-induced cardiac injury through modulation of endothelial nitric oxide synthase expression and transforming growth factor-b1signalling. Prospect Pharm Sci 2025: 24.
  6. Zarzynska JM. Two faces of TGF-beta1 in breast cancer. Mediators Inflamm 2014; 2014: 141747.
  7. Chan EWC, Wong SK, Chan HT. An overview on the chemistry, pharmacology and anticancer properties of tetrandrine and fangchinoline (alkaloids) from Stephania tetrandra roots. J Integr Med 2021; 19: 311-316.
  8. Zhang Y, Qi D, Gao Y, Liang C, Zhang Y, Ma Z, et al. History of uses, phytochemistry, pharmacological activities, quality control and toxicity of the root of Stephania tetrandra S. Moore: a review. J Ethnopharmacol 2020; 260: 112995.
  9. Fletcher T, Thompson AJ, Ashrafian H, Darzi A. The measurement and modification of hypoxia in colorectal cancer: overlooked but not forgotten. Gastroenterol Rep (Oxf) 2022; 10: goac042.
  10. Yang J, Hu S, Wang C, Song J, Chen C, Fan Y, et al. Fangchinoline derivatives induce cell cycle arrest and apoptosis in human leukemia cell lines via suppression of the PI3K/AKT and MAPK signaling pathway. Eur J Med Chem 2020; 186: 111898.
  11. Zhang W, Yu X, Bao L, He T, Pan W, Li P, et al. Bisbenzylisoquinoline alkaloid fangchinoline derivative HY-2 inhibits breast cancer cells by suppressing BLM DNA helicase. Biomed Pharmacother 2023; 169: 115908.
  12. Wang N, Pan W, Zhu M, Zhang M, Hao X, Liang G, et al. Fangchinoline induces autophagic cell death via p53/sestrin2/AMPK signalling in human hepatocellular carcinoma cells. Br J Pharmacol 2011; 164: 731-742.
  13. Wang CD, Yuan CF, Bu YQ, Wu XM, Wan JY, Zhang L, et al. Fangchinoline inhibits cell proliferation via Akt/GSK-3beta/cyclin D1 signaling and induces apoptosis in MDA-MB-231 breast cancer cells. Asian Pac J Cancer Prev 2014; 15: 769-773.
  14. Wang B, Long S, Lan J, Luo K, Zhang W, Li X, et al. Derived from fangchinoline, LYY-35 exhibits an inhibiting effect on human NSCLC cancer A549 cells. J Cancer 2024; 15: 4232-4243.
  15. Liu T, Liu X, Li W. Tetrandrine, a Chinese plant-derived alkaloid, is a potential candidate for cancer chemotherapy. Oncotarget 2016; 7: 40800-40815.
  16. Satria D, Hasibuan PA, Masfria M, Waruwu SB, Yeun-Mun C, Hermanto FE, et al. In silico approach and in vitro study of fangchinoline-induced apoptosis and reactive oxygen species production in HER2-overexpressing breast cancer cells. Contemp Oncol 2026; 30: 56–67.
  17. Satria D, Waruwu SB, Sholikhah EN, Mustofa M, Satriyo PB, Wahyuningsih TD, et al. In Silico study of N-pyrazoline derivate compounds as anticancer through inhibition of PI3K and PR expression. Baghdad Sci J 2026; 23: 2.
  18. Satria D, Waruwu, SB, Sholikhah, EN, Satriyo PB, Wahyuningsih, TD, Wiraswati HL, et al. In-silico analysis of N-phenyl pyrazoline derivates as potential of human epidermal growth receptor-2 (HER-2) inhibitor using molecular docking and MD simulations. Rasayan J Chem 2024; 17: 2.
  19. Satria D, Hasibuan PAZ, Muhammad M, Waruwu SB, Utomo RY, Ghoran SH. Cytotoxic and apoptotic effect of Vernonia amygdalina Delile. fractions against Hs578t triple-negative breast cancer cell lines. Phytomedicine Plus 2024; 4: 100640.
  20. Hasibuan PAZ, Sitorus RKUAB, Hermawan A, Huda F, Waruwu SB, Satria D. Anticancer activity of the ethylacetate fraction of Vernonia amygdalina Delile towards overexpression of HER-2 breast cancer cell lines. Pharmacia 2024; 71: 1-8.
  21. Chatri M, Hasibuan PAZ, Meiyanto E, Deddi Prima Putra. Effect of African leaves (vernonia amygdalina delile) on the development of T47D breast cancer cells. Tropical J Nat Product Res 2024; 8: 7740-7746.
  22. Satria D, Waruwu SB, Sholikhah EN, Mustofa M, Satriyo PB, Wahyuningsih TD, et al. The activity of pyrazoline B compound in inhibiting proliferation of breast cancer cells with human epidermal growth factor receptor 2 overexpression. Contemp Oncol 2024; 29: 360-366.
  23. Tian F, Ding D, Li D. Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells [retracted in: Int J Oncol 2023; 63: 99. doi: 10.3892/ijo.2023.5547.]. Int J Oncol 2015; 46: 2355-2363.
  24. Jiang Y, Liu J, Zhou Z, Liu K, Liu C. Fangchinoline protects against renal injury in diabetic nephropathy by modulating the MAPK signaling pathway. Exp Clin Endocrinol Diabetes 2020; 128: 499-505.
  25. Xiang X, Tian Y, Hu J, Xiong R, Bautista M, Deng L, et al. Fangchinoline exerts anticancer effects on colorectal cancer by inducing autophagy via regulation AMPK/mTOR/ULK1 pathway. Biochem Pharmacol 2021; 186: 114475.
  26. Massagué J. TGF signalling in context. Nat Rev Mol Cell Biol 2012; 13: 616-630.
  27. Batlle E, Massagué J. Transforming growth factor-signaling in immunity and cancer. Immunity 2019; 50: 924-940.
  28. Gao XZ, Lv XT, Zhang R, Luo Y, Wang MX, Chen JS, et al. Design, synthesis and in vitro anticancer research of novel tetrandrine and fangchinoline derivatives. Bioorg Chem 2021; 109: 104694.
  29. Li J, Cen W, Tong C, Wang L, Zhang W, Deng S, et al. Fangchinoline induces gallbladder cancer cell apoptosis by suppressing PI3K/Akt/XIAP axis. PLoS One 2022; 17: e0266738.
  30. Xiang X, Tian Y, Hu J, Xiong R, Bautista M, Deng L, et al. Fangchinoline exerts anticancer effects on colorectal cancer by inducing autophagy via regulation AMPK/mTOR/ULK1 pathway. Biochem Pharmacol 2021; 186: 114475.
  31. Mérarchi M, Sethi G, Fan L, Mishra S, Arfuso F, Seok Ahn K. Molecular targets modulated by fangchinoline in tumor cells and preclinical models. Molecules 2018; 23: 2538.
  32. Syahfitri A, Satria D, Hasibuan PAZ, Keliat JM, Waruwu SB, Yeun-Mun C. Docking-based virtual screening of bisbenzylisoquinoline derivatives from Stephania genus against hepatocellular carcinoma. Baghdad Sci J 2026; 23: 4.
Copyright: © 2026 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
SUBMIT YOUR PAPER
Share
without publication fees
Coverage in
Indexed in
pubmed
Integrated with
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications